Prescribe, deprescribe, and review — with confidence, at every stage of dementia.
Standard guidelines weren’t written for the way medication needs shift as dementia progresses. MATCH-D was. Built by Australian geriatricians, GPs, pharmacists, and dementia experts, it helps you make decisions that stay aligned with each person’s goals of care.
Why MATCH-D
Most people living with dementia take medications for other health conditions — but the evidence guiding those decisions usually wasn’t built with dementia in mind. Generic prescribing guidelines treat dementia as a comorbidity, not as the central factor reshaping every medication choice.
As dementia progresses, the balance of benefit and harm shifts. A medication that was appropriate at diagnosis may stop being so as cognition, function, and life expectancy change.
MATCH-D fills that gap. Consensus-based recommendations specific to early, mid, and late-stage dementia give clinicians, pharmacists, and care teams a shared starting point for prescribing, deprescribing, and review conversations.
Recommendations by stage
Choose the stage that matches your patient
Early Stage
Mild cognitive impairment with preserved ability to self-care and undertake activities of daily living.
Mid Stage
Moderate cognitive impairment with physical function often preserved. Living with support in the community or low-care residential.
Late Stage
Severe cognitive impairment and declining function. Inability to recognise loved ones; incontinence; loss of independent ambulation.
All Stages
Side-by-side comparison of recommended and not-recommended practices across early, mid, and late stage dementia.
Who MATCH-D is for
- General Practitioners
- Pharmacists
- Geriatricians
- Researchers